Comparison between Global Health IPO and Kaynes Technology IPO.
Global Health IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Kaynes Technology IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Global Health IPO is up to ₹2,205.57 Cr whereas the issue size of the Kaynes Technology IPO is up to ₹857.82 Cr. The final issue price of Global Health IPO is ₹336.00 per share and of Kaynes Technology IPO is ₹587.00 per share.
| Global Health IPO | Kaynes Technology IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹319.00 per share | ₹559.00 per share |
| Issue Price (Upper) | ₹336.00 per share | ₹587.00 per share |
| Issue Price (Final) | ₹336.00 per share | ₹587.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 44 shares | 25 shares |
| Fresh Issue Size | 1,48,80,952 shares | 90,28,960 shares |
| Fresh Issue Size (Amount) | up to ₹500.00 Cr | up to ₹530.00 Cr |
| OFS Issue Size | 5,07,61,000 shares | 55,84,664 shares |
| OFS Issue Size (Amount) | up to ₹1,705.57 Cr | up to ₹327.82 Cr |
| Issue Size Total | 6,56,41,952 shares | 1,46,13,624 shares |
| Issue Size Total (Amount) | up to ₹2,205.57 Cr | up to ₹857.82 Cr |
Global Health IPO opens on Nov 03, 2022, while Kaynes Technology IPO opens on Nov 10, 2022. The closing date of Global Health IPO and Kaynes Technology IPO is Nov 07, 2022, and Nov 14, 2022, respectively.
| Global Health IPO | Kaynes Technology IPO | |
|---|---|---|
| Anchor Bid Date | Nov 02, 2022 | Nov 09, 2022 |
| Issue Open | Nov 03, 2022 | Nov 10, 2022 |
| Issue Close | Nov 07, 2022 | Nov 14, 2022 |
| Basis Of Allotment (Tentative) | Nov 11, 2022 | Nov 17, 2022 |
| Initiation of Refunds (Tentative) | Nov 14, 2022 | Nov 18, 2022 |
| Credit of Share (Tentative) | Nov 15, 2022 | Nov 21, 2022 |
| Listing date (Tentative) | Nov 16, 2022 | Nov 22, 2022 |
| Anchor Lockin End date 1 | Dec 11, 2022 | Dec 17, 2022 |
| Anchor Lockin End date 2 | Feb 09, 2023 | Feb 15, 2023 |
Global Health IPO P/E ratio is 38.36, as compared to Kaynes Technology IPO P/E ratio of 84.95.
| Global Health IPO | Kaynes Technology IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 35 | 79.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 33 | 67.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 38.36 | 84.95 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹9011.01 Cr. | ₹3412.97 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 13.1 | 24.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 16.3 | 24.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.50 | 0.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.78 | ₹9.70 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 12.14 | 20.54 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Global Health IPO Retail Individual Investors (RII) are offered 2,29,74,684 shares while in Kaynes Technology IPO retail investors are offered 2,29,74,684 shares. Qualified Institutional Buyers (QIB) are offered 1,31,28,391 shares in Global Health IPO and 29,17,614 shares in Kaynes Technology IPO.
| Global Health IPO | Kaynes Technology IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,96,92,584 shares | 43,76,421 shares |
| Market Maker Reservation | ||
| QIB | 1,31,28,391 shares | 29,17,614 shares |
| NII | 98,46,293 shares | 21,88,211 shares |
| RII | 2,29,74,684 shares | 51,05,825 shares |
| Employee | 25,553 shares | |
| Others | ||
| Total | 6,56,41,952 shares | 1,46,13,624 shares |
Global Health IPO subscribed 9.58x in total, whereas Kaynes Technology IPO subscribed 34.16x.
| Global Health IPO | Kaynes Technology IPO | |
|---|---|---|
| QIB (times) | 28.64x | 98.47x |
| NII (times) | 4.02x | 21.21x |
| Big NII (times) | 5.16x | 23.07x |
| Small NII (times) | 1.73x | 17.47x |
| RII (times) | 0.88x | 4.10x |
| Employee (times) | 11.92x | |
| Other (times) | ||
| Total (times) | 9.58x | 34.16x |
